The price of Dexcom Inc (NASDAQ:DXCM) shares last traded on Wall Street rose 3.89% to $75.25.
DXCM stock price is now -30.80% away from the 50-day moving average and -36.15% away from the 200-day moving average. The market capitalization of the company currently stands at $30.15B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $161 to $80, Robert W. Baird Downgraded its rating from Outperform to Neutral for Dexcom Inc (NASDAQ: DXCM). On July 26, 2024, JP Morgan Downgraded its previous ‘Overweight’ rating to ‘Neutral’ on the stock reducing its target price from $145 to quote $75, while ‘Redburn Atlantic’ rates the stock as ‘Neutral’
In other news, MICHAEL BROWN, Officer bought 652 shares of the company’s stock on Jul 31 ’24. The stock was bought for $45,347 at an average price of $69.55. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 31 ’24, EVP, Chief Legal Officer Brown Michael Jon sold 652 shares of the business’s stock. A total of $45,347 was realized by selling the stock at an average price of $69.55. This leaves the insider owning 66,249 shares of the company worth $4.99 million. A total of 1.36% of the company’s stock is owned by insiders.
During the past 12 months, Dexcom Inc has had a low of $62.34 and a high of $142.00. As of last week, the company has a debt-to-equity ratio of 1.07, a current ratio of 2.82, and a quick ratio of 2.48. According to the stock market information, the enterprise value for the company is $29628293120, which is based on a 46.37 price-to-earnings ratio, a 2.86 price-to-earnings-growth ratio, and a beta of 1.12. The fifty day moving average price for DXCM is $107.7356 and a two-hundred day moving average price translates $117.81575 for the stock.
The latest earnings results from Dexcom Inc (NASDAQ: DXCM) was released for 2024-06-30. The net profit margin was 16.95% and return on equity was 29.41% for DXCM. The company reported revenue of $1.0 billion for the quarter, compared to $871.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.26 percent. For the current quarter, analysts expect DXCM to generate $989.76M in revenue.
